NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ·Healthcare·Biotechnology
$30.55
+0.94%
Mkt Cap $3.54B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (11 analysts)
$46.00
Range $37.00 – $55.00
Implied Upside
+50.6%
Consensus $46.00 vs current $30.55
NASDAQ·Healthcare·Biotechnology
$30.55
+0.94%
Mkt Cap $3.54B
Buy
4
Hold
0
Sell
0
Price Target (11 analysts)
$46.00
Range $37.00 – $55.00
+50.6%
Consensus $46.00 vs current $30.55